Last updated on November 2019

A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)


Brief description of study

This study designed to evaluate the long-term efficacy and safety of mirikizumab in participants with moderately to severely active ulcerative colitis (UC).

Clinical Study Identifier: NCT03519945

Find a site near you

Start Over

Pusat Perubatan University Kebangsaan Malaysia

Cheras, Kuala Lumpur, Malaysia
3.86miles
  Connect »

Hospital Ampang

Ampang, Malaysia
5.13miles
  Connect »

University Malaya Medical Centre

Kuala Lumpur, Malaysia
6.68miles
  Connect »